Chief Financial Officer
Anjeza Gjino was appointed Chief Financial Officer in January 2025, after serving as interim CFO since July 2024.
She drives financial and strategic leadership for SparingVision, overseeing capital allocation, fundraising, M&A, investor relations, HR, and legal.
Previously, Anjeza was CFO and Corporate Secretary at Cyclerion Therapeutics – a company that she was instrumental in launching and taking public in2019. Prior to Cyclerion, she held financial leadership roles at Ironwood Pharmaceuticals and PerkinElmer.
Anjeza holds an MBA from the Massachusetts Institute of Technology and a BS in Corporate Finance from Bentley University. She is based in Boston, USA.